China Pharma Hldgs Inc (NYSEMKT:CPHI)

CAPS Rating: 1 out of 5

Results 1 - 20 of 22 : 1 2 Next »

Recs

0
Member Avatar ChinaBottom (< 20) Submitted: 6/24/2011 12:00:47 AM : Outperform Start Price: $2.05 CPHI Score: -145.17

Tracking portfolio for China based companies that gained listings on US exchanges (Nasdaq, NYSE, or Amex) after conducting reverse mergers. Stocks that have been delisted have been omitted. Start date: Jun 24, average P/E of these companies: 3.

Recs

1
Member Avatar BuffettJunior1 (97.60) Submitted: 6/14/2011 1:51:44 PM : Underperform Start Price: $2.34 CPHI Score: +145.17

I've learned a little trick these Chinese companies are using. Have you noticed they all have China in their name? How many companies do you know that have America, Canada, Germany, etc... in their names? The reason they put China in their name is to draw in foreign investors, because China means growth. Most of these companies are frauds and you should stay away from them.

Recs

0
Member Avatar ChinaRTO (99.89) Submitted: 4/14/2011 3:27:53 AM : Underperform Start Price: $2.53 CPHI Score: +144.48

This is a tracking portfolio of all CAPS-ratable tickers in the Chinese RTO/SPAC space (i.e., companies that listed without filing an IPO).

China Pharma Holdings, Inc. went public via a reverse merger in 2005. The company is based in China.

Recs

0
Member Avatar Muhadi (51.62) Submitted: 12/25/2010 2:49:54 PM : Outperform Start Price: $2.80 CPHI Score: -152.25

Solid company, just need to stop diluting shareholders.

Recs

0
Member Avatar Brian33032 (26.84) Submitted: 11/20/2010 10:45:14 PM : Outperform Start Price: $2.90 CPHI Score: -159.99

3Y EPS>10%/yr, P/E < 20, insider interest, P/B < 20

Recs

0
Member Avatar whomonkyoulus (28.37) Submitted: 10/13/2010 12:53:31 PM : Outperform Start Price: $2.63 CPHI Score: -177.44

Real healthcare products in China. Cash flows are good.
Max PE ~14
Min PE ~5

Recs

0
Member Avatar TweggyGorilla (68.21) Submitted: 4/26/2010 1:10:20 PM : Outperform Start Price: $3.34 CPHI Score: -158.00

Low P/E, good growth, low PEG

Recs

0
Member Avatar mdhsp (< 20) Submitted: 3/26/2010 3:51:35 PM : Outperform Start Price: $3.38 CPHI Score: -165.19

At current P/E, with these fundamentals, sitting comfortable in the fastest growing economy in the world, backed here by the top Fools on this board... seems like a no brainer to me.

Recs

0
Member Avatar rkm1901 (63.09) Submitted: 3/12/2010 2:15:38 PM : Outperform Start Price: $3.53 CPHI Score: -167.41

Bulishbao chose this, and he's the top leader so....

Recs

0
Member Avatar brfishe (< 20) Submitted: 3/5/2010 12:16:31 PM : Outperform Start Price: $3.46 CPHI Score: -169.91

solid company, short term sell off has made this a great buying opportunity

Recs

0
Member Avatar ross812 (34.33) Submitted: 2/24/2010 8:47:58 AM : Outperform Start Price: $3.81 CPHI Score: -176.66

CPHI is worth at least $4.

Recs

0
Member Avatar thievaryx (88.47) Submitted: 1/14/2010 10:40:32 AM : Outperform Start Price: $4.16 CPHI Score: -169.63

Tremendous growth prospects, solid history

Recs

0
Member Avatar Morien (< 20) Submitted: 12/24/2009 2:06:25 PM : Outperform Start Price: $3.90 CPHI Score: -172.08

Very efficient and great growth/value. This stock, even after the price increase, still looks attractive.

Recs

0
Member Avatar buysell2 (< 20) Submitted: 12/6/2009 5:46:42 PM : Outperform Start Price: $3.80 CPHI Score: -175.12

A big run up in price BUT with Rev and Earns Growth up 53% an 39% respectively and a 7.6 P/E how can you ignore it?

Recs

1
Member Avatar brianpivar (< 20) Submitted: 12/5/2009 3:11:27 AM : Outperform Start Price: $3.80 CPHI Score: -175.12

Unbelievable fundamentals.. Current P/e 7.5, forward p/e 6.31
PEG: .44
Price/sales: 2.75
Price/book: 1.86
Profit Margin: 35%
Revenue growth: 25%
mmmm...chinese medicine

Recs

0
Member Avatar scoobamang (< 20) Submitted: 12/4/2009 9:53:49 PM : Outperform Start Price: $3.80 CPHI Score: -175.12

Chinese pharmaceuticals! Little debt, great fundamentals.

Recs

0
Member Avatar titliest78 (< 20) Submitted: 12/2/2009 4:16:53 PM : Outperform Start Price: $3.75 CPHI Score: -173.99

Generic high occurance drug/medical manufacturer in China with low visibility and strong financials. This could be a nice long term multibagger.

Recs

1
Member Avatar dantefromsomm (< 20) Submitted: 11/10/2009 11:51:11 PM : Outperform Start Price: $3.29 CPHI Score: -175.13

undervalued

Recs

1
Member Avatar Schmevbo (42.96) Submitted: 12/6/2007 1:37:38 PM : Outperform Start Price: $3.47 CPHI Score: -134.01

Short term I think I may take a hit getting in at this point but long term seems to be an utter no brainer.

Recs

0
Member Avatar walterboylan (30.24) Submitted: 11/16/2007 9:29:11 PM : Outperform Start Price: $3.25 CPHI Score: -137.73

Love the numbers of this company. Anything in Asia is golden at this moment in my opinion.

Results 1 - 20 of 22 : 1 2 Next »

Featured Broker Partners


Advertisement